Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across Canada
Pfizer Canada and Colorectal Cancer Canada
The intent of this RFP is to encourage the applicant Canadian organizations and institutions to pursue innovative approaches for Research or QI projects that aim to optimize molecular testing for patients in metastatic CRC at the applicant' centre. Applicants are invited to implement innovative ideas with the goal of creating a path for sustainable molecular testing for cancer patients in Caanda.
The total available budget related to this RFP is $300,000. Individual projects requesting up to a maximum of $100,000 will be considered.
Deadlines
| UM Internal Deadline | Sponsor Deadline | |
|---|---|---|
Application | 28-Mar-2025 4:30 pm CST | 17-Apr-2025 11:59 pm EST |
Important
The information in this directory is provided as a service to the University Community and anyone with legitimate business with the University. Use of this directory to prepare mass mailings is prohibited.